CHFS - CHF Solutions, Inc.
| Previous Close | 1.11 |
| Open | 1.09 |
| Bid | 1.08 x 1100 |
| Ask | 1.20 x 1100 |
| Day's Range | 1.09 - 1.14 |
| 52 Week Range | 0.93 - 24.45 |
| Volume | 91,040 |
| Avg. Volume | 258,469 |
| Market Cap | 7.711M |
| Beta (3Y Monthly) | 3.96 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -10.16 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 15.00 |
- GlobeNewswire•6 days ago
CHF Solutions Initiates Strategic Collaboration with NI Medical on Management of Fluid Overloaded Patients
CHF Solutions, Inc. (CHFS) announced today that it has entered into a collaboration agreement with NI Medical to explore potential clinical synergies between the company’s Aquadex FlexFlow® System and NI Medical’s NICaS Hemodynamic Navigator to assess patient’s fluid volume status and assist by informing on the management of a fluid overloaded patient. The collaboration will initiate with a small patient evaluation when combining the Aquadex FlexFlow system with NI Medical’s, already 510k cleared, NICaS Hemodynamic Navigator in clinical practice.
- GlobeNewswire•14 days ago
CHF Solutions to Attend Southwest Nephrology Conference and Cardio Renal Metabolic Conference
EDEN PRAIRIE, Minn., Oct. 03, 2018 -- CHF Solutions, Inc. (Nasdaq: CHFS) today announced that the company will be an exhibitor at the 19th Annual Southwest Nephrology.
- GlobeNewswire•22 days ago
CHF Solutions to Present at 2018 Ladenburg Thalmann Healthcare Conference October 2, 2018
EDEN PRAIRIE, Minn., Sept. 25, 2018 -- CHF Solutions (Nasdaq: CHFS), today announced that John Erb, chairman and CEO will present at the 2018 Ladenburg Thalmann Healthcare.
- GlobeNewswire•27 days ago
Recently Presented Data Demonstrate Benefits of CHF Solutions’ Aquadex FlexFlow® System in Managing Fluid Overload in Heart Failure Patients from the United Kingdom
EDEN PRAIRIE, Minn., Sept. 20, 2018-- CHF Solutions, Inc. announced today results from a poster recently presented by a United Kingdom’ s National Health Service hospital that demonstrated ultrafiltration ...
- GlobeNewswire•last month
CHF Solutions Expands Commercial Focus of Fluid Overloaded Patients into the Post-Cardiovascular Surgery Market
EDEN PRAIRIE, Minn., Sept. 13, 2018-- CHF Solutions, Inc., today announced that it is expanding its commercial focus into the post-cardiovascular surgery market, where, like in heart failure, patients ...
- GlobeNewswire•last month
CHF Solutions, Inc. to Attend the 22nd Annual Scientific Meeting of the Heart Failure Society of America
CHF Solutions, Inc. (CHFS) is a medical device company focused on commercializing the Aquadex FlexFlow system for Aquapheresis therapy. The Aquadex FlexFlow® system is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.
- GlobeNewswire•last month
CHF Solutions, Inc. Acquires Impedance Technology from Vasamed, Inc.
EDEN PRAIRIE, Minn., Sept. 05, 2018-- CHF Solutions, Inc. announced today it has acquired the AcQtrac™ System technology from Vasamed, Inc. The AcQtrac System is a patented, non-invasive device designed ...
- GlobeNewswire•2 months ago
CHF Solutions, Inc. Completes In-House Manufacturing Capabilities with Initiation of Catheter Production
EDEN PRAIRIE, Minn., Aug. 23, 2018-- CHF Solutions, Inc., today announced it has now completed the transition of all manufacturing activities related to Aquadex FlexFlow ® with the initiation of in-house ...
- GlobeNewswire•2 months ago
CHF Solutions, Inc. Extends Reach in Asia with Distribution in Thailand
EDEN PRAIRIE, Minn., Aug. 21, 2018-- CHF Solutions, Inc. announced today that the company received registration from FDA Thailand to allow the sale of Aquadex Flex Flow ® in Thailand. The product will ...
- GlobeNewswire•2 months ago
CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
CHF Solutions, Inc. (CHFS), today announced that on August 15, 2018, the independent directors approved seven equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to seven individuals entering into employment with the Company. The equity awards were approved in accordance with NASDAQ Listing Rule 5635(c)(4), which also requires a public announcement of equity awards that are not made under a stockholder approved equity plan. In connection with entering into employment with CHF Solutions, the seven individuals, who were not previously employees or directors of CHF Solutions, received options to purchase an aggregate of 169,440 shares of the Company’s common stock. CHF Solutions, Inc. (CHFS) is a medical device company focused on commercializing the Aquadex FlexFlow system for Aquapheresis® therapy.
- GlobeNewswire•2 months ago
CHF Solutions, Inc. Announces 27% Revenue Growth for its Second Quarter and Provides Company Update
EDEN PRAIRIE, Minn., Aug. 07, 2018-- CHF Solutions, Inc. announced today its second quarter results for the period ended June 30, 2018. Revenue for second quarter ended June 30, 2018 increased 27 percent ...
- ACCESSWIRE•2 months ago
CHF Solutions Inc to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / August 7, 2018 / CHF Solutions Inc (NASDAQ: CHFS ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 7, 2018 at 9:00:00 AM Eastern Time. ...
- GlobeNewswire•3 months ago
CHF Solutions, Inc. To Announce Second Quarter Financial Results on August 7, 2018
EDEN PRAIRIE, Minn., July 31, 2018-- CHF Solutions, Inc. announces today that its second quarter 2018 financial results will be released on Tuesday, August 7, 2018. The company will host a conference call ...
- GlobeNewswire•3 months ago
Department of Veterans Affairs Awards a $6.5 million Blanket Purchase Agreement to CHF Solutions to Supply Aquadex FlexFlow System for Outpatient Services in Tampa, Fla.
EDEN PRAIRIE, Minn., July 25, 2018-- As previously disclosed on its website, FedBizOps.gov, the United States Department of Veterans Affairs has awarded CHF Solutions, Inc. a blanket purchase agreement ...
- Simply Wall St.•4 months ago
CHF Solutions Inc (NASDAQ:CHFS): Does The Earnings Decline Make It An Underperformer?
Examining CHF Solutions Inc’s (NASDAQ:CHFS) past track record of performance is a useful exercise for investors. It allows us to reflect on whether the company has met or exceed expectations,Read More...
- ACCESSWIRE•4 months ago
Free Research Reports on Boston Scientific and Three More Medical Equipment Stocks
Today's research coverage on WallStEquities.com is focused on four Medical Appliances and Equipment stocks, particularly, Boston Scientific Corp. (NYSE: BSX), Cesca Therapeutics Inc. (NASDAQ: KOOL), CHF Solutions Inc. (NASDAQ: CHFS), and Intuitive Surgical Inc. (NASDAQ: ISRG).
- Simply Wall St.•5 months ago
Does CHF Solutions Inc’s (NASDAQ:CHFS) Past Performance Indicate A Weaker Future?
When CHF Solutions Inc’s (NASDAQ:CHFS) announced its latest earnings (31 March 2018), I wanted to understand how these figures stacked up against its past performance. The two benchmarks I usedRead More...
